GB0918450D0 - Composition - Google Patents

Composition

Info

Publication number
GB0918450D0
GB0918450D0 GBGB0918450.8A GB0918450A GB0918450D0 GB 0918450 D0 GB0918450 D0 GB 0918450D0 GB 0918450 A GB0918450 A GB 0918450A GB 0918450 D0 GB0918450 D0 GB 0918450D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0918450.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
Innovata Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovata Ltd filed Critical Innovata Ltd
Priority to GBGB0918450.8A priority Critical patent/GB0918450D0/en
Publication of GB0918450D0 publication Critical patent/GB0918450D0/en
Priority to PCT/GB2010/001955 priority patent/WO2011048379A2/en
Priority to JP2012534763A priority patent/JP2013508344A/ja
Priority to US13/501,303 priority patent/US20130004542A1/en
Priority to CA2777899A priority patent/CA2777899C/en
Priority to CN2010800478259A priority patent/CN102665684A/zh
Priority to EP10781721.5A priority patent/EP2490670B1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0918450.8A 2009-10-21 2009-10-21 Composition Ceased GB0918450D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0918450.8A GB0918450D0 (en) 2009-10-21 2009-10-21 Composition
PCT/GB2010/001955 WO2011048379A2 (en) 2009-10-21 2010-10-21 Composition
JP2012534763A JP2013508344A (ja) 2009-10-21 2010-10-21 組成物
US13/501,303 US20130004542A1 (en) 2009-10-21 2010-10-21 Composition
CA2777899A CA2777899C (en) 2009-10-21 2010-10-21 Composition for inhalation comprising a pharmaceutically acceptable glassy matrix
CN2010800478259A CN102665684A (zh) 2009-10-21 2010-10-21 用于吸入的组合物
EP10781721.5A EP2490670B1 (en) 2009-10-21 2010-10-21 Composition for inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0918450.8A GB0918450D0 (en) 2009-10-21 2009-10-21 Composition

Publications (1)

Publication Number Publication Date
GB0918450D0 true GB0918450D0 (en) 2009-12-09

Family

ID=41426476

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0918450.8A Ceased GB0918450D0 (en) 2009-10-21 2009-10-21 Composition

Country Status (7)

Country Link
US (1) US20130004542A1 (enExample)
EP (1) EP2490670B1 (enExample)
JP (1) JP2013508344A (enExample)
CN (1) CN102665684A (enExample)
CA (1) CA2777899C (enExample)
GB (1) GB0918450D0 (enExample)
WO (1) WO2011048379A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
MX354829B (es) 2009-03-26 2018-03-22 Pulmatrix Operating Co Inc Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares.
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
EP2464346A1 (en) 2010-08-30 2012-06-20 Pulmatrix, Inc. Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
CA2809666C (en) 2010-08-30 2020-09-22 Michael M. Lipp Dry powder formulations and methods for treating pulmonary diseases
AU2011314007B2 (en) 2010-09-29 2017-01-19 Pulmatrix, Inc. Cationic dry powders
RU2640921C2 (ru) 2010-09-29 2018-01-12 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
US20150165038A1 (en) * 2012-02-10 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Compositions comprising muscarinic receptor antagonist and sorbitol
JP2015509788A (ja) 2012-02-29 2015-04-02 パルマトリックス，インコーポレイテッド 吸入に適した乾燥粉末
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007769A1 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Compositions comprising muscarinic receptor antagonist and glucose anhydrous
US10105316B2 (en) 2012-07-05 2018-10-23 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising muscarinic receptor antagonist
UA115989C2 (uk) * 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
AU2013368298B2 (en) * 2012-12-27 2016-08-11 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
CN104885172B (zh) * 2012-12-27 2019-12-13 3M创新有限公司 电化学装置及其制造方法
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
JP2015116367A (ja) * 2013-12-19 2015-06-25 重人 下山 寝具装置、寝具装置制御方法及びプログラム
CN103830194A (zh) * 2014-03-11 2014-06-04 熊妲妮 茚达特罗固体分散体及含有其的药物组合物
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
WO2017100656A1 (en) * 2015-12-11 2017-06-15 Otitopic Inc. Dry powder formulations of aspirin for inhalation
AU2019207288A1 (en) * 2018-01-11 2020-08-13 Emphysema Solutions Bv Compositions and methods for the treatment of lung emphysema and other forms of COPD
GB201817861D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Gel and crystalline powder
US20250049862A1 (en) * 2021-12-16 2025-02-13 Alveolus Bio, Inc. Spray dried inhalable biotherapeutics for the treatment of disease
CN115046816B (zh) * 2022-03-11 2025-09-26 桂林优利特医疗电子有限公司 一种尿液有形成分分析仪用结晶质控物的制备方法
US12605394B2 (en) 2024-07-25 2026-04-21 Visionary Assets, Llc Compositions containing cannabinoid nanoparticles

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8802174D0 (en) 1988-02-01 1988-03-02 Quadrant Bioresources Ltd Method of drying macromolecules
AU5414990A (en) 1989-04-12 1990-11-05 Aberdeen University Slow release vitreous systems
GB9107628D0 (en) 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
EP0563455A1 (en) 1992-03-31 1993-10-06 Purac Biochem B.V. Particulate solid products containing a lump forming inhibitor
EP0611567B1 (en) * 1992-06-12 2002-08-28 Teijin Limited Ultrafine powder for inhalation and production thereof
ES2218543T3 (es) 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
JP3095624B2 (ja) 1994-07-19 2000-10-10 株式会社ボッシュオートモーティブシステム 積層型熱交換器の偏平チューブのろう付け方法
DE69531992T2 (de) 1994-08-04 2004-07-22 Elan Drug Delivery Ltd., Ruddington Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US6258341B1 (en) 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
JP4502406B2 (ja) 1995-06-07 2010-07-14 クアドラント、ドラッグ、デリバリー、リミテッド 乾燥発泡ガラスマトリックス内に物質を安定に配合する方法及びそれによって得られた組成物
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
GB9621825D0 (en) 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
AU2945199A (en) 1998-03-18 1999-10-11 Ronai, Peter Amorphous glasses for stabilising sensitive products
DK1283036T3 (da) 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
PL196951B1 (pl) 1999-03-05 2008-02-29 Chiesi Farma Spa Proszek do stosowania w inhalatorze suchego proszku, cząsteczki nośnika i sposób wytwarzania nośnika
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10050995A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
DE10141376A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
JP2003062074A (ja) * 2001-08-29 2003-03-04 Tomohiko Hashiba 吸入装置
DE10203749A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203753A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203741A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
EP1480996A1 (en) * 2002-02-04 2004-12-01 Glaxo Group Limited Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
WO2003079993A2 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION
WO2004060343A1 (en) 2002-12-31 2004-07-22 Nektar Therapeutics Antibody-containing particles and compositions
JP2005060330A (ja) * 2003-08-18 2005-03-10 Tomohiko Hashiba 球状タンパク質粉体とその製造方法
GB0520794D0 (en) 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
MX354829B (es) * 2009-03-26 2018-03-22 Pulmatrix Operating Co Inc Formulaciones de polvo seco y metodos para el tratamiento de enfermedades pulmonares.
AU2010229730A1 (en) * 2009-03-26 2011-10-06 Pulmatrix, Inc. Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining

Also Published As

Publication number Publication date
WO2011048379A2 (en) 2011-04-28
CA2777899A1 (en) 2011-04-28
WO2011048379A3 (en) 2012-01-05
EP2490670A2 (en) 2012-08-29
JP2013508344A (ja) 2013-03-07
CN102665684A (zh) 2012-09-12
CA2777899C (en) 2016-03-29
US20130004542A1 (en) 2013-01-03
EP2490670B1 (en) 2019-04-17

Similar Documents

Publication Publication Date Title
GB0908129D0 (en) Composition
ZA201109176B (en) Homeglobin compositions
IL217949A0 (en) Pesticdal compositions
GB0905863D0 (en) Novel composition
GB0906515D0 (en) Fungical compositions
GB0911428D0 (en) Composition
ZA201107839B (en) Composition
EP2462514A4 (en) GREEN BOOKS
ZA201107838B (en) Composition
GB0909362D0 (en) Composition
PL2393887T3 (pl) Kompozycja
GB0908642D0 (en) Composition
IL216395A0 (en) Prothrombic complex composition
GB0906779D0 (en) Composition
GB0904941D0 (en) Composition
GB0922389D0 (en) composition
GB201006350D0 (en) Composition
GB0911294D0 (en) Composition
GB0904942D0 (en) Composition
GB0905165D0 (en) Compositions
GB0918590D0 (en) Composition
GB0903688D0 (en) Composition
GB0912768D0 (en) Novel composition
GB0922133D0 (en) Composition
GB0902959D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)